Our partnership-enabled business model focuses on forging strategic collaborations with and licensing patented technologies to leading medical device companies to drive successful global commercialization of product candidates we develop. We focus on advancing promising therapeutic solutions, such as BackBeat CNT (also known as AVIM therapy) and Virtue SAB, through late-stage clinical research and regulatory approvals, while our partners focus on leveraging their commercial expertise and existing infrastructure to bring our product candidates to global markets quickly and efficiently.
